Lipocine Inc. (LPCN) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of Lipocine Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LPCN
Lipocine Inc.
$2.09HealthcareDelayed quote: Oct 6, 2026, 12:22 PM EDT
PTN
Palatin Technologies, Inc.
$9.42HealthcareDelayed quote: Oct 6, 2026, 12:17 PM EDT
Total return — LPCN vs PTN
growth of $100 · dividends reinvested · last 10yLPCN -97.2% (-30.0%/yr)PTN -98.8% (-35.6%/yr)LPCN compounded faster over this window
LPCN PTN
LPCN vs PTN: by the numbers
- •LPCN is the larger company ($17M vs $17M market cap).
- •Both run net losses; PTN's is the smaller (-63.54% vs -755.13% net margin).
Metrics side by side
Valuation
| Metric | LPCN | PTN |
|---|---|---|
| P/S ratio | 10.95 | 1.27 |
| P/B ratio | 0.79 | 2.51 |
Profitability
| Metric | LPCN | PTN |
|---|---|---|
| Gross margin | -334.26% | 99.63% |
| Operating margin | -524.69% | -65.74% |
| Net margin | -755.13% | -63.54% |
| ROE | -54.45% | -125.30% |
| ROIC | -57.74% | -125.44% |
Growth (annualized)
| Metric | LPCN | PTN |
|---|---|---|
| Total return CAGR (5Y) | -34.76% | -55.41% |
Frequently asked
- How have LPCN and PTN total returns compared?
- Over the past 10 years, LPCN delivered -29.99% and PTN delivered -35.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.